GBR and The Hemobag®
Global Blood Resources is pleased to present this website for health professionals. Our products The Hemobag® and TS3 Tubing Set, which have been cleared for clinical use by the FDA and have CE marking and Canadian registration, are a new way to help conserve autologous whole blood and increase the safety of blood infusion. Blood is one of the most precious substances on the planet and we want to help you conserve it for your patients.
The Hemobag® is the only autotransfusion product on the market salvaging and concentrating all autologous whole blood fractions and constituents for CardioThoracic and Vascular Surgery, helping to avoid unnecessary allogeneic blood product use.
This technique offers perfusionists a new role in optimizing hemostasis and homeostasis hours after the termination of surgery. Saving More Blood, Reducing Costs, and Improving Patient Outcomes!
Watch a testimonial video explaining why the Hemobag is important: The Hemobag and Patient Blood Management (SABM).
- Shaw, R. E., Johnson, C. K., Ferrari, G., Brizzio, M. E., Sayles, K., Rioux, N., Zapolanski, A. and Grau, J. B. (2013), Blood transfusion in cardiac surgery does increase the risk of 5-year mortality: results from a contemporary series of 1714 propensity-matched patients. Transfusion. doi: 10.1111/trf.12364
- Aryeh Shander, Gross I, Hill S, Mazyar Javidroozi, Sledge S A new perspective on best transfusion practices blood transfusion. 2013. DOI 10.2450/2012.0195-12
- Beckmann S, Lynn P, Miller S, Harris R, DiMarco RF, Ross JE. Evaluation of coagulation factors and platelet function from an off-line modified ultrafiltration technique for post-cardiopulmonary bypass circuit blood recovery. Perfusion. 2013 May;28(3):214-22. doi: 10.1177/0267659112470710. Epub 2012 Dec 27.
- Jeffrey L. Carson, MD; Brenda J. Grossman, et. al Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB. Ann Intern Med. 26 March 2012.
- Kruer RM, Ensor CR. Colloids in the intensive care unit. Am J Health Syst Pharm. 2012 Oct 1;69(19):1635-42.
- Torina AG, Silveira-Filho LM, Vilarinho KA, Eghtesady P, Oliveira PP, Sposito AC, Petrucci O Use of modified ultrafiltration in adults undergoing coronary artery bypass grafting is associated with inflammatory modulation and less postoperative blood loss: a randomized and controlled study. J Thorac Cardiovasc Surg. 2012 Sep;144(3):663-70. doi: 10.1016/j.jtcvs.2012.04.012. Epub 2012 May 9.
- Harm S, Waters J, Lynn P, Dyga R, Raval J, DiMarco R, Yazer M Changes in Mechanical Fragility and Free Hemoglobin Levels after Processing Salvaged Cardiopulmonary Bypass Circuit Blood with a Modified Ultrafiltration Device. JECT. 2012;44:21–25
- Economics of Blood Management - AmSECT 18th Annual Symposium in Blood Management (Jackson Hole, WY, August 11 - 14, 2010)
- Delaney E, Rosinski D, Ellis H, Samolyk KA, Riley JB An In-Vitro Comparison between Hemobag® and Non-Hemobag® Ultrafiltration Methods of Salvaging Circuit Blood Following Cardiopulmonary Bypass JECT 2010;42:128–133.
- Comparison of Methodologies for ECC Salvage With Ultrafiltration Post CPB in Cardiac Surgery - AmSECT 48th International Conference (Reno, Nevada, May 1, 2010)
- Drastic Coagulation Improvements Post CV Surgery Without the Use of Blood Products - AmSECT 48th International Conference (Reno, Nevada, May 1, 2010)
- Modified Ultrafiltration with the Hemobag® - presentation at Case Reports in the Sun V (Tampa, Florida, Oct. 8-11, 2009)
- A Case for Blood Conservation: Transfusion Risks, Outcomes and Costs - Bruce Spiess, MD
- Samolyk KA. State of the art blood management in cardiac surgery. Outcomes 2008: Key West Meeting May 21st-24th, 2008, Barbados, WI
- Samolyk KA. State-of-the-art blood management in cardiac surgery. Semin Cardiothorac Vasc Anesth 2009 Jun;13(2):118-21.
- Fox J, Brown A, Vigil R. Bloodless surgery and patient safety issues. Perioperative Nursing Clinics 2008 Dec; 3(4):345-54.
- Samolyk K, Beckman S. Have we missed something? Whole blood conservation and management in cardiac surgery: costs, ethics and best practices. (Poster, SABM 2006 Annual Meeting) Transfusion 2007;47(2):3A.
- Moskowitz, DM, Klein JJ, Shander A, Perelman SI, McMurtry KA, Cousineau KM, Ergin MA. Use of the Hemobag® for modified ultrafiltration in a Jehovah’s Witness patient undergoing cardiac surgery. JECT 2006;38:265–70.
- Riley JB, Samolyk KA, Lich BV, Moskowitz B, Shander A. Results from the Perfusion.com cardiac surgery hematocrit trend survey: observations and evidence-based recommendations.
- Samolyk KA, Beckmann SR, Bissinger RC. A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag®. Perfusion
- Is it the best practice to throw away clotting factors and plasma proteins? Achieving the maximum patient benefit from residual ECC blood based on evidence (The Boston Meeting, New Foundation of Perfusion. The Cardiac Surgery Team Meeting.) [1.43 MB]
- A method to reduce allogeneic blood exposure and hospital costs while preserving clotting factor concentration after cardiopulmonary bypass ("2006 Outcomes Key West Meeting")
With The Hemobag® patients receive their own concentrated Whole Blood or concentrated hyperoncotic blood quickly without the time delay experienced with other techniques or technologies.
Patients also benefit because its their own plasma and its constituents (plasma proteins, clotting factors and platelets) included in the salvaged Whole Blood.
More on the Hemobag®
Great video on hemostasis and coagulation